Abbott wins EU approval for diabetes management device

09/18/2013 | BioSpectrum Asia

The FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System by Abbott has secured the CE mark to be commercialized in Europe. The diabetes management device comes with blood glucose trend indicators to alert patients when their sugar levels are high or low and an insulin dose feature to enable clinicians to program an insulin therapy plan into the monitor.

View Full Article in:

BioSpectrum Asia

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC